☰

Jamie A. Pineda, Ph.D. - Publications

Affiliations: 
Cognitive Science University of California, San Diego, La Jolla, CA 
Area:
Neurobiology of social cognition, attention, face perception, addiction, monoamines, brain-computer interfaces
Website:
http://bci.ucsd.edu/~pineda/CNL_WEBPAGE/index.html
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Datko M, Pineda J, Müller RA. Positive effects of neurofeedback on autism symptoms correlate with brain activation during imitation and observation. The European Journal of Neuroscience. PMID 28245068 DOI: 10.1111/ejn.13551  0.382
2016 Neukam K, Espinosa N, Collado A, Delgado-Fernández M, Jiménez-Aguilar P, Rivero-Juárez A, Hontañón-Antoñana V, Gómez-Berrocal A, Ruiz-Morales J, Merino D, Carrero A, Téllez F, Ríos MJ, Hernández-Quero J, de Lagarde-Sebastián M, ... ... Pineda JA, et al. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. Plos One. 11: e0155842. PMID 27195797 DOI: 10.1371/journal.pone.0155842  0.324
2015 Pineda JA, Núñez-Torres R, Téllez F, Mancebo M, García F, Merchante N, Pérez-Pérez M, Neukam K, Macías J, Real LM. Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C. The Journal of Infection. 71: 571-7. PMID 26212868 DOI: 10.1016/j.jinf.2015.07.006  0.308
2015 Monje-Agudo P, Castro-Iglesias A, Rivero-Juárez A, Martínez-Marcos F, Ortega-González E, Real LM, Pernas B, Merchante N, Cid P, Macías J, Merino MD, Rivero A, Mena A, Neukam K, Pineda JA, et al. Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 34: 1929-36. PMID 26155784 DOI: 10.1007/s10096-015-2434-6  0.304
2015 Rockstroh JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA. Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents. Hiv Clinical Trials. 16: 72-80. PMID 25923596 DOI: 10.1179/1528433614Z.0000000011  0.301
2015 Rivero-Juarez A, Martinez-Dueñas L, Martinez-Peinado A, Camacho A, Cifuentes C, Gordon A, Frias M, Torre-Cisneros J, Pineda JA, Rivero A. Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients. The Journal of Infection. 70: 680-3. PMID 25453620 DOI: 10.1016/j.jinf.2014.11.010  0.304
2013 Macías J, Márquez M, Téllez F, Merino D, Jiménez-Aguilar P, López-Cortés LF, Ortega E, von Wichmann MA, Rivero A, Mancebo M, Santos J, Pérez-Pérez M, Suárez-Lozano I, Romero-Palacios A, Torres-Cornejo A, ... Pineda JA, et al. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1401-8. PMID 23946224 DOI: 10.1093/cid/cit537  0.308
2013 Rivero-Juárez A, Camacho A, Merchante N, Pérez-Camacho I, Macias J, Ortiz-Garcia C, Cifuentes C, Torre-Cisneros J, Peña J, Pineda JA, Rivero A. Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV. Plos One. 8: e68953. PMID 23874824 DOI: 10.1371/journal.pone.0068953  0.322
2013 Neukam K, Barreiro P, Macías J, Avellón A, Cifuentes C, Martín-Carbonero L, Echevarría JM, Vargas J, Soriano V, Pineda JA. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 465-8. PMID 23575198 DOI: 10.1093/cid/cit224  0.309
2013 Mira JA, Rivero-Juárez A, López-Cortés LF, Girón-González JA, Téllez F, de los Santos-Gil I, Macías J, Merino D, Márquez M, Ríos-Villegas MJ, Gea I, Merchante N, Rivero A, Torres-Cornejo A, Pineda JA, et al. Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1646-53. PMID 23429381 DOI: 10.1093/cid/cit103  0.32
2013 Rivero-Juarez A, Mira JA, Camacho A, Neukam K, Perez-Camacho I, Caruz A, Macias J, Torre-Cisneros J, Pineda JA, Rivero A. Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV. Infection. 41: 21-6. PMID 23065463 DOI: 10.1007/s15010-012-0352-4  0.324
2012 Mira JA, Rivero A, de Los Santos-Gil I, López-Cortés LF, Girón-González JA, Márquez M, Merino D, del Mar Viloria M, Téllez F, Ríos-Villegas MJ, Omar M, Rivero-Juárez A, Macías J, Pineda JA. Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients. Aids (London, England). 26: 1721-4. PMID 22695304 DOI: 10.1097/QAD.0b013e3283568884  0.329
2012 Macías J, Berenguer J, Japón MA, Girón-González JA, Rivero A, López-Cortés LF, Moreno A, Márquez M, Iribarren JA, Ortega E, Miralles P, Merchante N, Pineda JA. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology (Baltimore, Md.). 56: 1261-70. PMID 22508322 DOI: 10.1002/hep.25791  0.306
2012 García-Jurado L, Oyagüez I, Casado MÁ, Tural C, González-García J, Ortega E, Pineda JA. [Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus]. Enfermedades Infecciosas Y Microbiologã­a Clã­Nica. 30: 294-9. PMID 22197275 DOI: 10.1016/j.eimc.2011.11.004  0.306
2011 Neukam K, Mira JA, Ruiz-Morales J, Rivero A, Collado A, Torres-Cornejo A, Merino D, de Los Santos-Gil I, Macías J, González-Serrano M, Camacho A, Parra-García G, Pineda JA. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients. The Journal of Antimicrobial Chemotherapy. 66: 2605-14. PMID 21903660 DOI: 10.1093/jac/dkr357  0.304
2011 Rivero-Juárez A, Mira JA, Pérez-Camacho I, Macías J, Camacho A, Neukam K, Torre-Cisneros J, Merchante N, Pineda JA, Rivero A. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients. The Journal of Antimicrobial Chemotherapy. 66: 1351-3. PMID 21415037 DOI: 10.1093/jac/dkr091  0.312
2011 Macías J, Neukam K, Portilla J, Iribarren JA, de Los Santos I, Rivero A, Márquez M, Delgado M, Téllez F, Merino D, Giner L, von Wichmann MA, Pineda JA. Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C. The Journal of Antimicrobial Chemotherapy. 66: 1346-50. PMID 21398295 DOI: 10.1093/jac/dkr083  0.326
2009 Pineda JA, Aguilar-Guisado M, Rivero A, Girón-González JA, Ruiz-Morales J, Merino D, Ríos-Villegas MJ, Macías J, López-Cortés LF, Camacho A, Merchante N, Del Valle J. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1274-82. PMID 19772387 DOI: 10.1086/605676  0.317
2009 Pérez Cachafeiro S, Del Amo J, Iribarren JA, Salavert Lleti M, Gutiérrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, Moreno S. Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1467-70. PMID 19368502 DOI: 10.1086/598333  0.322
2009 Moreno S, García-Samaniego J, Moreno A, Ortega E, Pineda JA, del Romero J, Tural C, von Wichmann MA, Berenguer J, Castro A, Espacio R. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. Journal of Viral Hepatitis. 16: 249-58. PMID 19215579 DOI: 10.1111/j.1365-2893.2009.01088.x  0.308
2008 Macías J, Recio E, Vispo E, Rivero A, López-Cortés LF, Ríos MJ, Merino D, González M, Barreiro P, de Lédinghen V, Quereda C, Pineda JA. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. Journal of Hepatology. 49: 916-22. PMID 18929426 DOI: 10.1016/j.jhep.2008.07.031  0.307
2008 Mira JA, López-Cortés LF, Barreiro P, Tural C, Torres-Tortosa M, de Los Santos Gil I, Martín-Rico P, Ríos-Villegas MJ, Hernández-Burruezo JJ, Merino D, López-Ruz MA, Rivero A, Muñoz L, González-Serrano M, Collado A, ... ... Pineda JA, et al. Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone. The Journal of Antimicrobial Chemotherapy. 62: 1365-73. PMID 18854330 DOI: 10.1093/jac/dkn420  0.314
2008 Vispo E, Barreiro P, Pineda JA, Mira JA, Maida I, Martín-Carbonero L, Rodríguez-Nóvoa S, Santos I, López-Cortes LF, Merino D, Rivero A, Soriano V. Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir. Antiviral Therapy. 13: 429-37. PMID 18572756  0.307
2008 Pineda JA, Santos J, Rivero A, Abdel-Kader L, Palacios R, Camacho A, Lozano F, Macías J. Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis. The Journal of Antimicrobial Chemotherapy. 61: 925-32. PMID 18276600 DOI: 10.1093/jac/dkn045  0.306
2003 García-García JA, Mira JA, Fernández-Rivera J, Ramos AJ, Vargas J, Macías J, Pineda JA. Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 22: 194-6. PMID 12649720 DOI: 10.1007/s10096-003-0888-4  0.302
1998 Macías J, Pineda JA, Leal M, Abad MA, García-Pesquera F, Delgado J, Gallardo JA, Sánchez-Quijano A, Lissen E. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 17: 167-70. PMID 9665297  0.301
Show low-probability matches.